Browse by Journal Title

2023

Mitochondrial DNA mutations as natural barcodes for lineage tracing of murine tumor models.
Penter, L. and Ten Hacken, E. and Southard, J. and Lareau, C. and Ludwig, L.S. and Li, S. and Neuberg, D.S. and Livak, K.J. and Wu, C.J.
Cancer Research 83 (5): 667-672. 1 March 2023

2022

Noncanonical function of AGO2 augments T-cell receptor signaling in T-cell prolymphocytic leukemia.
Braun, T. and Stachelscheid, J. and Bley, N. and Oberbeck, S. and Otte, M. and Müller, T.A. and Wahnschaffe, L. and Glaß, M. and Ommer, K. and Franitza, M. and Gathof, B. and Altmüller, J. and Hallek, M. and Auguin, D. and Hüttelmaier, S. and Schrader, A. and Herling, M.
Cancer Research 82 (9): 1818-1831. 1 May 2022

2021

Subclone eradication analysis identifies targets for enhanced cancer therapy and reveals L1 retrotransposition as a dynamic source of cancer heterogeneity.
Ketola, K. and Kaljunen, H. and Taavitsainen, S. and Kaarijärvi, R. and Järvelä, E. and Rodriguez Martin, B. and Haase, K. and Woodcock, D.J. and Tubio, J. and Wedge, D.C. and Nykter, M. and Bova, G.S.
Cancer Research 81 (19): 4901-4909. October 2021

YAP and β-catenin cooperate to drive oncogenesis in basal breast cancer.
Quinn, H.M. and Vogel, R. and Popp, O. and Mertins, P. and Lan, L. and Messerschmidt, C. and Landshammer, A. and Lisek, K. and Château-Joubert, S. and Marangoni, E. and Koren, E. and Fuchs, Y. and Birchmeier, W.
Cancer Research 81 (8): 2116-2127. April 2021

2020

Lymphoma angiogenesis is orchestrated by noncanonical signaling pathways.
Gloger, M. and Menzel, L. and Grau, M. and Vion, A.C. and Anagnostopoulos, I. and Zapukhlyak, M. and Gerlach, K. and Kammertöns, T. and Hehlgans, T. and Zschummel, M. and Lenz, G. and Gerhardt, H. and Höpken, U.E. and Rehm, A.
Cancer Research 80 (6): 1316-1329. March 2020

Phosphorylation of RAB7 by TBK1/IKKε regulates innate immune signaling in triple negative breast cancer.
Ritter, J.L. and Zhu, Z. and Thai, T.C. and Mahadevan, N.R. and Mertins, P. and Knelson, E.H. and Piel, B.P. and Han, S. and Jaffe, J.D. and Carr, S.A. and Barbie, D.A. and Barbie, T.U.
Cancer Research 80 (1): 44-56. January 2020

2019

Targeting APLN/APLNR improves antiangiogenic efficiency and blunts proinvasive side effects of VEGFA/VEGFR2 blockade in glioblastoma.
Mastrella, G. and Hou, M. and Li, M. and Stoecklein, V.M. and Zdouc, N. and Volmar, M.N.M. and Miletic, H. and Reinhard, S. and Herold-Mende, C.C. and Kleber, S. and Eisenhut, K. and Gargiulo, G. and Synowitz, M. and Vescovi, A.L. and Harter, P.N. and Penninger, J.M. and Wagner, E. and Mittelbronn, M. and Bjerkvig, R. and Hambardzumyan, D. and Schüller, U. and Tonn, J.C. and Radke, J. and Glass, R. and Kälin, R.E.
Cancer Research 79 (9): 2298-2313. May 2019

2018

ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice.
Schmidt, K. and Keller, C. and Kühl, A.A. and Textor, A. and Seifert, U. and Blankenstein, T. and Willimsky, G. and Kloetzel, P.M.
Cancer Research 78 (12): 3243-3254. June 2018

Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple-negative breast cancers.
Mundt, F. and Rajput, S. and Li, S. and Ruggles, K.V. and Mooradian, A.D. and Mertins, P. and Gillette, M.A. and Krug, K. and Guo, Z. and Hoog, J. and Erdmann-Gilmore, P. and Primeau, T. and Huang, S. and Edwards, D.P. and Wang, X. and Wang, X. and Kawaler, E. and Mani, D.R. and Clauser, K.R. and Gao, F. and Luo, J. and Davies, S.R. and Johnson, G.L. and Huang, K.L. and Yoon, C.J. and Ding, L. and Fenyö, D. and Ellis, M.J. and Townsend, R.R. and Held, J.M. and Carr, S.A. and Ma, C.X.
Cancer Research 78 (10): 2732-2746. May 2018

Adaptive and reversible resistance to Kras inhibition in pancreatic cancer cells.
Chen, P.Y. and Muzumdar, M.D. and Dorans, K.J. and Robbins, R.A. and Bhutkar, A. and Del Rosario, A.M. and Mertins, P. and Qiao, J. and Schaefer, C. and Gertler, F.B. and Carr, S.A. and Jacks, T.
Cancer Research 78 (4): 985-1002. 15 February 2018

2017

CTLA4 promotes Tyk2-STAT3 dependent B-cell oncogenecity.
Herrmann, A. and Lahtz, C. and Nagao, T. and Song, J.Y. and Chan, W.C. and Lee, H. and Yue, C. and Look, T. and Muelfarth, R. and Li, W. and Jenkins, K. and Williams, J. and Budde, L.E. and Forman, S.J. and Kwak, L.W. and Blankenstein, T. and Yu, H.
Cancer Research 77 (18): 5118-5128. 15 September 2017

Chimeric PD-1:28 receptor upgrades low-avidity T cells and restores effector function of tumor-infiltrating lymphocytes for adoptive cell therapy.
Schlenker, R. and Olguín-Contreras, L.F. and Leisegang, M. and Schnappinger, J. and Disovic, A. and Rühland, S. and Nelson, P.J. and Leonhardt, H. and Harz, H. and Wilde, S. and Schendel, D.J. and Uckert, W. and Willimsky, G. and Noessner, E.
Cancer Research 77 (13): 3577-3590. 1 July 2017

Drug resistance mechanisms in colorectal cancer dissected with cell type-specific dynamic logic models.
Eduati, F. and Doldan-Martelli, V. and Klinger, B. and Cokelaer, T. and Sieber, A. and Kogera, F. and Dorel, M. and Garnett, M.J. and Blüthgen, N. and Saez-Rodriguez, J.
Cancer Research 77 (12): 3364-3375. 15 June 2017

Cellular and molecular identity of tumor-associated macrophages in glioblastoma.
Chen, Z. and Feng, X. and Herting, C.J. and Alvarez Garcia, V. and Nie, K. and Pong, W.W. and Rasmussen, R. and Dwivedi, B. and Seby, S. and Wolf, S.A. and Gutmann, D.H. and Hambardzumyan, D.
Cancer Research 77 (9): 2266-2278. 1 May 2017

Cancer stem cells regulate cancer-associated fibroblasts via activation of Hedgehog signaling in mammary gland tumors.
Valenti, G. and Quinn, H.M. and Heynen, G.J.J.E. and Lan, L. and Holland, J.D. and Vogel, R. and Wulf-Goldenberg, A. and Birchmeier, W.
Cancer Research 77 (8): 2134-2147. 15 April 2017

2016

Splenic marginal zone granulocytes acquire an accentuated neutrophil B cell-helper phenotype in chronic lymphocytic leukemia.
Gätjen, M. and Brand, F. and Grau, M. and Gerlach, K. and Kettritz, R. and Westermann, J. and Anagnostopoulos, I. and Lenz, P. and Lenz, G. and Höpken, U.E. and Rehm, A.
Cancer Research 76 (18): 5253-5265. 15 September 2016

Circulating omentin as a novel biomarker for colorectal cancer risk: Data from the EPIC - Potsdam cohort study.
Aleksandrova, K. and di Giuseppe, R. and Isermann, B. and Biemann, R. and Schulze, M.B. and Wittenbecher, C. and Fritsche, A. and Lehmann, R. and Menzel, J. and Weikert, C. and Pischon, T. and Boeing, H.
Cancer Research 76 (13): 3862-3871. 1 July 2016

Delivery of therapeutics targeting the mRNA-binding protein HuR using 3DNA nanocarriers suppresses ovarian tumor growth.
Huang, Y.H. and Peng, W. and Furuuchi, N. and Gerhart, J. and Rhodes, K. and Mukherjee, N. and Jimbo, M. and Gonye, G.E. and Brody, J.R. and Getts, R.C. and Sawicki, J.A.
Cancer Research 76 (6): 1549-1559. 15 March 2016

A small-molecule antagonist of the β-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis.
Fang, L. and Zhu, Q. and Neuenschwander, M. and Specker, E. and Wulf-Goldenberg, A. and Weis, W.I. and von Kries, J.P. and Birchmeier, W.
Cancer Research 76 (4): 891-901. 15 February 2016

2014

Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ.
Textor, A. and Listopad, J.J. and Wührmann, L.L. and Perez, C. and Kruschinski, A. and Chmielewski, M. and Abken, H. and Blankenstein, T. and Charo, J.
Cancer Research 74 (23): 6796-6805. 1 December 2014

Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling.
van Noort, V. and Schoelch, S. and Iskar, M. and Zeller, G. and Ostertag, K. and Schweitzer, C. and Werner, K. and Weitz, J. and Koch, M. and Bork, P.
Cancer Research 74 (20): 5690-5699. 15 October 2014

Mouse models of human cancer.
Böck, B.C. and Stein, U. and Schmitt, C.A. and Augustin, H.G.
Cancer Research 74 (17): 4671-4675. 1 September 2014

B-cell expansion and lymphomagenesis induced by chronic CD40 signaling is strictly dependent on CD19.
Hojer, C. and Frankenberger, S. and Strobl, L.J. and Feicht, S. and Djermanovic, K. and Jagdhuber, F. and Hömig-Hölzel, C. and Ferch, U. and Ruland, J. and Rajewsky, K. and Zimber-Strobl, U.
Cancer Research 74 (16): 4318-4328. 15 August 2014

GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
Fabian, J. and Lodrini, M. and Oehme, I. and Schier, M.C. and Thole, T.M. and Hielscher, T. and Kopp-Schneider, A. and Opitz, L. and Capper, D. and von Deimling, A. and Wiegand, I. and Milde, T. and Mahlknecht, U. and Westermann, F. and Popanda, O. and Roels, F. and Hero, B. and Berthold, F. and Fischer, M. and Kulozik, A.E. and Witt, O. and Deubzer, H.E.
Cancer Research 74 (9): 2604-2616. 1 May 2014

Axon guidance factor Slit2 inhibits neural invasion and metastasis in pancreatic cancer.
Goehrig, A. and Detjen, K.M. and Hilfenhaus, G. and Koerner, J. and Welzel, M. and Arsenic, R. and Schmuck, R. and Bahra, M. and Wu, J.Y. and Wiedenmann, B. and Fischer, C.
Cancer Research 74 (5): 1529-1540. 1 March 2014

2013

PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating graft-versus-host-disease.
Ghosh, A. and Holland, A.M. and Dogan, Y. and Yim, N. and Rao, U.K. and Young, L.F. and West, M.L. and Singer, N.V. and Lee, H. and Na, I.K. and Tsai, J.J. and Jenq, R. and Penack, O. and Hanash, A.M. and Lezcano, C. and Murphy, G.F. and Liu, C. and Sadelain, M. and Sauer, M.G. and Sant'Angelo, D. and van den Brink, M.R.M.
Cancer Research 73 (15): 4687-4696. 1 August 2013

Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T cell transplantation.
Hess Michelini, R. and Manzo, T. and Sturmheit, T. and Basso, V. and Rocchi, M. and Freschi, M. and Listopad, J.J. and Blankenstein, T. and Bellone, M. and Mondino, A.
Cancer Research 73 (15): 4641-4652. 1 August 2013

Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens.
Zhang, J and Chen, L and Liu, X and Kammertoens, T. and Blankenstein, T. and Qin, Z.
Cancer Research 73 (9): 2770-2781. 1 May 2013

2012

Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition Cohort.
Aleksandrova, K. and Boeing, H. and Jenab, M. and Bueno-de-Mesquita, H.B. and Jansen, E. and van Duijnhoven, F.J.B. and Rinaldi, S. and Fedirko, V. and Romieu, I. and Riboli, E. and Gunter, M.J. and Westphal, S. and Overvad, K. and Tjonneland, A. and Halkjaer, J. and Racine, A. and Boutron-Ruault, M.C. and Clavel-Chapelon, F. and Kaaks, R. and Lukanova, A. and Trichopoulou, A. and Lagiou, P. and Trichopoulos, D. and Mattiello, A. and Pala, V. and Palli, D. and Tumino, R. and Vineis, P. and Buckland, G. and Sanchez, M.J. and Amiano, P. and Huerta, J.M. and Barricarte, A. and Menendez, V. and Peeters, P.H. and Soederberg, S. and Palmqvist, R. and Allen, N.E. and Crowe, F.L. and Khaw, K.T. and Wareham, N. and Pischon, T.
Cancer Research 72 (20): 5328-5337. 15 October 2012

Uncoupling of PI3K from ErbB3 impairs mammary gland development but does not impact on ErbB2-induced mammary tumorigenesis.
Lahlou, H. and Mueller, T. and Sanguin-Gendreau, V. and Birchmeier, C. and Muller, W.J.
Cancer Research 72 (12): 3080-3090. 15 June 2012

2011

CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.
Henrich, K.O. and Bauer, T. and Schulte, J. and Ehemann, V. and Deubzer, H. and Gogolin, S. and Muth, D. and Fischer, M. and Benner, A. and König, R. and Schwab, M. and Westermann, F.
Cancer Research 71 (8): 3142-3151. 15 April 2011

Protein kinase C inhibitor Sotrastaurin selectively inhibits the growth of CD79-mutant diffuse large B-cell lymphomas.
Naylor, T.L. and Tang, H. and Ratsch, B.A. and Enns, A. and Loo, A. and Chen, L. and Lenz, P. and Schuler, W. and Doerken, B. and Yao, Y.M. and Warmuth, M. and Lenz, G. and Stegmeier, F.
Cancer Research 71 (7): 2643-2653. 1 April 2011

Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth.
Waaler, J. and Machon, O. and von Kries, J.P. and Wilson, S.R. and Lundenes, E. and Wedlich, D. and Gradl, D. and Paulsen, J.E. and Machonova, O. and Dembinski, J.L. and Dinh, H. and Krauss, S.
Cancer Research 71 (1): 197-205. 1 January 2011

2009

Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.
Johnsen, S.A. and Guengoer, C. and Prenzel, T. and Riethdorf, S. and Riethdorf, L. and Taniguchi-Ishigaki, N. and Rau, T. and Tursun, B. and Furlow, J.D. and Sauter, G. and Scheffner, M. and Pantel, K. and Gannon, F. and Bach, I.
Cancer Research 69 (1): 128-136. 1 January 2009

2008

Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts.
Nocito, A. and Dahm, F. and Jochum, W. and Jang, J.H. and Georgiev, P. and Bader, M. and Graf, R. and Clavien, P.A.
Cancer Research 68 (13): 5152-5158. 1 July 2008

2007

Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis.
Zhao, X. and Mohaupt, M. and Jiang, J. and Liu, S. and Li, B. and Qin, Z.
Cancer Research 67 (9): 4443-4450. 1 May 2007

2006

A1 adenosine receptors in microglia control glioblastoma-host interaction.
Synowitz, M. and Glass, R. and Faerber, K. and Markovic, D. and Kronenberg, G. and Herrmann, K. and Schnermann, J. and Nolte, C. and van Rooijen, N. and Kiwit, J. and Kettenmann, H.
Cancer Research 66 (17): 8550-8557. 1 September 2006

Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney.
Dekel, B. and Metsuyanim, S. and Schmidt-Ott, K.M. and Fridman, E. and Jacob-Hirsch, J. and Simon, A. and Pinthus, J. and Mor, Y. and Barasch, J. and Amariglio, N. and Reisner, Y.
Cancer Research 66 (12): 6040-6049. 15 June 2006

Oncogene-induced senescence: putting the brakes on tumor development.
Braig, M. and Schmitt, C.A.
Cancer Research 66 (6): 2881-2884. 15 March 2006

2005

YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification.
Bergmann, S. and Royer-Pokora, B. and Fietze, E. and Juerchott, K. and Hildebrandt, B. and Trost, D. and Leenders, F. and Claude, J.C. and Theuring, F. and Bargou, R. and Dietel, M. and Royer, H.D.
Cancer Research 65 (10): 4078-4087. 16 May 2005

CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells.
Kammertoens, T. and Willebrand, R. and Erdmann, B. and Li, L. and Li, Y. and Engels, B. and Uckert, W. and Blankenstein, T.
Cancer Research 65 : 2560-2564. 1 January 2005

Association of CYP1A1 polymorphisms with differential metabolic activation of 17beta-estradiol and estrone.
Kisselev, P. and Schunck, W.H. and Roots, I. and Schwarz, D.
Cancer Research 65 (7): 2972-2978. 1 January 2005

Characterization of gamma-aminobutyric acid type A receptor associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.
Klebig, C. and Seitz, S. and Arnold, W. and Deutschmann, N. and Pacyna-Gengelbach, M. and Scherneck, S. and Petersen, I.
Cancer Research 65 : 394-400. 1 January 2005

Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct.
Schlereth, B. and Fichtner, I. and Lorenczewski, G. and Kleindienst, P. and Brischwein, K. and da Silva, A. and Kufer, P. and Lutterbuese, R. and Junghahn, I. and Kasimir-Bauer, S. and Wimberger, P. and Kimmig, R. and Baeuerle, P.A.
Cancer Research 65 : 2882-2889. 1 January 2005

2004

Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: Impact for cancer gene therapy.
Holm, P.S. and Lage, H. and Bergmann, S. and Juerchott, K. and Glockzin, G. and Bernshausen, A. and Mantwill, K. and Ladhoff, A. and Wichert, A. and Mymryk, J.S. and Ritter, T. and Dietel, M. and Gaensbacher, B. and Royer, H.D.
Cancer Research 64 (1): 322-328. 1 January 2004

2003

A new approach for the treatment of malignant melanoma: Enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.
Mansour, A.M. and Drevs, J. and Esser, N. and Hamada, F.M. and Badary, O.A. and Unger, C. and Fichtner, I. and Kratz, F.
Cancer Research 63 (14): 4062-4066. 15 July 2003

A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8T cells.
Qin, Z.H. and Schwartzkopff, J. and Pradera, F. and Kammertoens, T. and Seliger, B. and Pircher, H. and Blankenstein, T.
Cancer Research 63 (14): 4095-4100. 1 January 2003

2002

Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion.
Nylandsted, J. and Wick, W. and Hirt, U.A. and Brand, K. and Rohde, M. and Leist, M. and Weller, M. and Jaeaettelae, M.
Cancer Research 62 (24): 7139-7142. 15 December 2002

Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.
LeBlanc, R. and Catley, L.P. and Hideshima, T. and Lentzsch, S. and Mitsiades, C.S. and Mitsiades, N. and Neuberg, D. and Goloubeva, O. and Pien, C.S. and Adams, J. and Gupta, D. and Richardson, P.G. and Munshi, N.C. and Anderson, K.C.
Cancer Research 62 (17): 4996-5000. 1 September 2002

The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment.
Lin, B. and Podar, K. and Gupta, D. and Tai, Y.T. and Li, S. and Weller, E. and Hideshima, T. and Lentzsch, S. and Davies, F. and Li, C. and Weisberg, E. and Schlossman, R.L. and Richardson, P.G. and Griffin, J.D. and Wood, J. and Munshi, N.C. and Anderson, K.C.
Cancer Research 62 : 5019-5026. 1 September 2002

Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors.
Qin, Z. and Harders, C. and Cao, X. and Huber, C. and Blankenstein, T. and Seliger, B.
Cancer Research 62 (10): 2856-2860. 15 May 2002

S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.
Lentzsch, S. and Rogers, M.S. and LeBlanc, R. and Birsner, A.E. and Shah, J.H. and Treston, A.M. and Anderson, K.C. and D'Amato, R.J.
Cancer Research 62 : 2300-2305. 15 April 2002

Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 21.
Kaufmann, D. and Leistner, W. and Kruse, P. and Kenner, O. and Hoffmeyer, S. and Hein, C. and Vogel, W. and Messiaen, L. and Bartelt, B.
Cancer Research 62 : 1503-1509. 1 January 2002

Circulating tumor-reactive CD8+ T cells in melanoma patients contain a CD45RA+CCR7- effector subset exerting ex vivo tumor-specific cytolytic activity.
Valmori, D. and Scheibenbogen, C. and Dutoit, V. and Nagorsen, D. and Asemissen, A.M. and Rubio-Godoy, V. and Rimoldi, D. and Guillaume, P. and Romero, P. and Schadendorf, D. and Lipp, M. and Dietrich, P.Y. and Thiel, E. and Cerottini, J.C. and Lienard, D. and Keilholz, U.
Cancer Research 62 : 1743-1750. 1 January 2002

2001

Overexpression of sialyltransferase CMP-sialic Acid : Galbeta1,3GalNAc-R alpha6-sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider, F. and Kemmner, W. and Haensch, W. and Franke, G. and Gretschel, S. and Karsten, U. and Schlag, P.M.
Cancer Research 61 (11): 4605-4611. 1 June 2001

Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
Dahmen, R.P. and Koch, A. and Denkhaus, D. and Tonn, J.C. and Soerensen, N. and Berthold, F. and Behrens, J. and Birchmeier, W. and Wiestler, O.D. and Pietsch, T.
Cancer Research 61 : 7039-7043. 1 January 2001

Protoporphyrin IX occurs naturally in colorectal cancers and their metastases.
Moesta, K.T. and Ebert, B. and Handke, T. and Nolte, D. and Nowak, C. and Haensch, W.E. and Pandey, R.K. and Dougherty, T.J. and Rinneberg, H. and Schlag, P.M.
Cancer Research 61 : 991-999. 1 January 2001

Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers.
Savelyeva, L. and Claas, A. and Matzner, I. and Schlag, P.M. and Hofmann, W. and Scherneck, S. and Weber, B. and Schwab, M.
Cancer Research 61 : 5179-5185. 1 January 2001

Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
Schumacher, K. and Haensch, W. and Roefzaad, C. and Schlag, P.M.
Cancer Research 61 : 3932-3936. 1 January 2001

Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.
Seliger, B. and Wollscheid, U. and Momburg, F. and Blankenstein, T. and Huber, C.
Cancer Research 61 : 1095-1099. 1 January 2001

Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL).
Varon, R. and Reis, A. and Henze, G. and von Einsiedel, H.G. and Sperling, K. and Seeger, K.
Cancer Research 61 : 3570-3572. 1 January 2001

2000

Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue.
Brand, K. and Baker, A.H. and Perez-Canto, A. and Possling, A. and Sacharjat, M. and Geheeb, M. and Arnold, W.
Cancer Research 60 (20): 5723-5730. 15 October 2000

The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: Assessment of antitumor efficacy and toxicity.
Wildner, O. and Morris, J.C.
Cancer Research 60 (15): 4167-4174. 1 August 2000

Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors.
Willimsky, G. and Blankenstein, T.
Cancer Research 60 (3): 685-692. 1 February 2000

Mitochondrial amplification of death signals determines thymidine kinase/ ganciclovir-triggered activation of apoptosis.
Beltinger, C. and Fulda, S. and Kammertoens, T. and Uckert, W. and Debatin, K.M.
Cancer Research 60 (12): 3212-3217. 1 January 2000

Anti-CD20-and B-cell receptor-mediated apoptosis: Evidence for shared intracellular signaling pathways.
Mathas, S. and Rickers, A. and Bommert, K. and Doerken, B. and Mapara, M.Y.
Cancer Research 60 (24): 7170-7176. 1 January 2000

1999

Two regions of deletion in 9p23-24 in sporadic breast cancer.
An, H.X. and Claas, A. and Savelyeva, L. and Seitz, S. and Schlag, P.M. and Scherneck, S. and Schwab, M.
Cancer Research 59 : 3941-3943. 15 August 1999

GLI gene expression in bone and soft tissue sarcomas of adult patients correlates with tumor grade.
Stein, U. and Eder, C. and Karsten, U. and Haensch, W. and Walther, W. and Schlag, P.M.
Cancer Research 59 : 1890-1895. 1 January 1999

1998

p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells1.
Welcker, M. and Lukas, J. and Strauss, M. and Bartek, J.
Cancer Research 58 (22): 5053-5056. 15 November 1998

Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
Karsten, U. and Diotel, C. and Klich, G. and Paulsen, H. and Goletz, S. and Mueller, S. and Hanisch, F.G.
Cancer Research 58 (12): 2541-2549. 15 June 1998

Consortium study on 1280 breast carcinomas: Allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan, C.M. and Borg, A. and Cuny, M. and Crichton, D.N. and Baldersson, T. and Andersen, T.I. and Caligo, M.A. and Lidereau, R. and Lindblom, A. and Seitz, S. and Kelsell, D. and Hamann, K. and Rio, P. and Thorlacius, S. and Papp, J. and Olah, E. and Ponder, B. and Bignon, Y.J. and Scherneck, S. and Barkardottir, R. and Borresen-Dale, A.L. and Eyfjoerd, J. and Theillet, C. and Thompson, A.M. and Devilee, P. and Larsson, C.
Cancer Research 58 (5): 1004-1012. 1 March 1998

An interstitial tandem duplication of 9p23-24 coexists with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer.
Savelyeva, L. and Claas, A. and Gier, S. and Schlag, P.M. and Finke, L. and Mangion, J. and Stratton, M.R. and Schwab, M.
Cancer Research 58 (5): 863-866. 1 March 1998

1997

Microsatellite instability analysis: a multicenter study for reliability and quality control.
Bocker, T. and Diermann, J. and Friedl, W. and Gebert, J. and Holinski-Feder, E. and Karner-Hanusch, J. and von Knebel-Doeberitz, M. and Koelble, K. and Moeslein, G. and Schackert, H.K. and Witz, H.C. and Fishel, R. and Rueschoff, J.
Cancer Research 57 (21): 4739-4743. 1 November 1997

A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells.
Hoffmann, J. and Schirner, M. and Menrad, A. and Schneider, M.R.
Cancer Research 57 (17): 3847-3851. 1 September 1997

1996

Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
Luebbe, A.S. and Bergemann, C. and Riess, H. and Schriever, F. and Reichardt, P. and Possinger, K. and Matthias, M. and Doerken, B. and Herrmann, F. and Guertler, R. and Hohenberger, P. and Haas, N. and Sohr, R. and Sander, B. and Lemke, A.J. and Ohlendorf, D. and Huhnt, W. and Huhn, D.
Cancer Research 56 (20): 4686-4693. 15 October 1996

Evaluation of efficient chemoembolization mixtures by magnetic resonance imaging therapy monitoring: an experimental study on the vx2 tumor in the rabbit liver.
Paeuser, S. and Wagner, S. and Lippmann, M. and Pohlen, U. and Reszka, R. and Wolf, K.J. and Berger, G.
Cancer Research 56 (8): 1863-1867. 15 April 1996

1995

Lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro.
Moesta, K.T. and Greco, W.R. and Nurse-Finlay, S.O. and Parsons, J.C. and Mang, T.S.
Cancer Research 55 (14): 3078-3084. 15 July 1995

High expression level of alpha6 integrin in human breast carcinoma is correlated with reduced survival.
Friedrichs, K. and Ruiz, P. and Franke, F. and Gille, I. and Terpe, H.J. and Imhof, B.A.
Cancer Research 55 (4): 901-906. 15 February 1995

Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response.
Qin, Z. and Blankenstein, T.
Cancer Research 55 (21): 4747-4751. 1 January 1995

1994

Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
Otto, T. and Birchmeier, W. and Schmidt, U. and Hinke, A. and Schipper, J. and Ruebben, H. and Raz, A.
Cancer Research 54 (12): 3120-3123. 15 June 1994

Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
Kotera, Y. and Fontenot, J.D. and Pecher, G. and Metzgar, R.S. and Finn, O.J.
Cancer Research 54 (11): 2856-2860. 1 June 1994

Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
Futreal, P.A. and Cochran, C. and Marks, J.R. and Iglehart, J.D. and Zimmerman, W. and Barrett, J.C. and Wiseman, R.W.
Cancer Research 54 (7): 1791-1794. 1 April 1994

Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.
Allione, A. and Consalvo, M. and Nanni, P. and Lollini, P.L. and Cavallo, F. and Giovarelli, M. and Forni, M. and Gulino, A. and Colombo, M.P. and Dellabona, P. and Hock, H. and Blankenstein, T. and Rosenthal, F.M. and Gansbacher, B. and Bosco, M.C. and Musso, T. and Gusella, L. and Forni, G.
Cancer Research 54 : 6022-6026. 1 January 1994

1993

Cytolysis of leukemic B-cells by T-cells activated via 2 bispecific antibodies.
Bohlen, H. and Manzke, O. and Patel, B. and Moldenhauer, G. and Doerken, B. and von Fliedner, V. and Diehl, V. and Tesch, H.
Cancer Research 53 (18): 4310-4314. 15 September 1993

Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration.
Richter, G. and Krueger-Krasagakes, S. and Hein, G. and Huels, C. and Schmitt, E. and Diamantstein, T. and Blankenstein, T.
Cancer Research 53 (18): 4134-4137. 15 September 1993

Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression.
Hanski, C. and Drechsler, K. and Hanisch, F.G. and Sheehan, J. and Manske, M. and Ogorek, D. and Klussmann, E. and Hanski, M.L. and Blank, M. and Xing, P.X. and McKenzie, I.F.C. and Devine, P.L. and Riecken, E.O.
Cancer Research 53 (17): 4082-4088. 1 September 1993

E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration.
Mayer, B. and Johnson, J.P. and Leitl, F. and Jauch, K.W. and Heiss, M.M. and Schildberg, F.W. and Birchmeier, W. and Funke, I.
Cancer Research 53 (7): 1690-1695. 1 April 1993

Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant.
Hock, H. and Dorsch, M. and Kunzendorf, U. and Ueberla, K. and Qin, Z. and Diamantstein, T. and Blankenstein, T.
Cancer Research 53 (4): 714-716. 15 February 1993